02/11/2025
4:58 PM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
5:30 AM | Nuvectis Pharma (Filer)
| Form 424B5 | |
02/05/2025
8:51 PM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:09 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:10 PM | Carson Michael J. (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:12 PM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:13 PM | Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:37 PM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4/A | |
12/16/2024
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:30 AM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NVCT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. |
11/18/2024
7:30 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
2:59 PM | Carson Michael J. (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
9:55 AM | Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
| Form SC 13G/A | |
11/05/2024
7:31 AM | Nuvectis Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:08 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
7:52 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
3:09 PM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:16 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:47 AM | Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:49 AM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:51 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:13 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:20 PM | Nuvectis Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
7:17 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
7:37 AM | Mosseri Marlio Charles (Filed by)
Nuvectis Pharma (Subject)
| Form SC 13G/A | |
